Answers are grounded in this paper and cite their sources.
A number of known 1,4-dihydropyridine CCBs were identified as having comparable potency to the steroidal MR antagonist eplerenone. Chiral resolution of mebudipine revealed that MR and CCB activity reside in opposite enantiomers. Small molecule X-ray crystal structures showed that the C4 stereochemistry of optimized selective MR analogues, e.g. 5, is consistent with MR-active mebudipine. Molecular modeling supports a binding pose consistent with that previously proposed for DHP diesters.
No takes yet. Share an insight, caveat, or question.
Arhancet et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: